Author: admin

  • President Droupadi Murmu Offers Prayers at Ram Janmabhoomi Temple, Calls for Unity and Inclusive Development

    AYODHYA, March 20: Droupadi Murmu visited the Shri Ram Janmabhoomi Mandir on Wednesday and offered prayers to Ram Lalla.

    During her visit, the President performed darshan and aarti at various locations within the temple complex. She also carried out the rituals of Shri Ram Yantra Sthapana and pujan.

    President Droupadi Murmu Offers Prayers at Ram Janmabhoomi Temple, Calls for Unity and Inclusive Development

     

    Addressing the gathering, Murmu described her visit as a “supreme privilege,” saying she felt blessed to be in Ayodhya, revered as the birthplace of Prabhu Shri Ram. She noted that the occasion coincided with Chaitra Shukla Pratipada, marking the beginning of Samvatsar 2083 and the first day of Navratri.

    The President said that key milestones related to the temple, including the Bhoomi Pujan, Pran Pratishtha of the idol, opening of the Ram Darbar, and installation of the temple flag, represent “golden moments” in India’s cultural and historical journey.

    Highlighting the vision of a developed and inclusive India, she expressed confidence that the country would achieve its goals by 2047 with the blessings of Lord Ram. She said the concept of Ram Rajya, as described by Goswami Tulsidas, reflects ideals of social harmony, prosperity, and moral values.

    President Droupadi Murmu Offers Prayers at Ram Janmabhoomi Temple, Calls for Unity and Inclusive Development

     

    Murmu said these principles align with India’s contemporary goals of social inclusion and economic justice. She added that the nation’s ongoing progress across economic, social, political, and cultural spheres reflects a broader renaissance.

    Calling for unity, the President urged citizens to work together in the spirit of devotion and shared responsibility to contribute to nation-building.

  • Wayne State University and Great Lakes Water Authority launch major collaboration to protect Lake Erie and Rouge River

    DETROIT – A research team led by Wayne State University was awarded a $473,566, three-year grant from the Great Lakes Water Authority (GLWA) for a major collaborative initiative focused on enhanced phosphorus removal at the nation’s largest single-site wastewater treatment facility.

    The GLWA Water Resource Recovery Facility (WRRF) serves 77 communities — including Detroit — and manages flows from a nearly 1,000‑square‑mile sewer shed. The project aims to protect the Rouge River and Lake Erie by improving phosphorus removal efficiency and ensuring compliance with increasingly stringent environmental regulations designed to reduce harmful algal blooms.

    “This project is critical for protecting the Great Lakes, which provide drinking water, food and recreation for many local communities,” said Dr. Shawn McElmurry, chair of Wayne State’s Department of Civil and Environmental Engineering in the James and Patricia Anderson College of Engineering. “Phosphorus enters our water systems through various ways like agricultural and urban runoff, sewage and waste, and when the amount entering the environment is too large, it can cause significant problems like algal blooms. It is critical that we continue to improve our ability to remove this nutrient to address these challenges.”

    The research team will develop a comprehensive understanding of how phosphorus moves through the WRRF using advanced chemical analyses to identify and quantify phosphorus species. They will build bench-scale treatment systems that allow controlled, side-by-side testing of biological and chemical processes to enhance phosphorus removal. Moreover, they will create new predictive models to help water treatment facility operators optimize phosphorus removal in real-time, which will advance data-driven water management.

    In addition to improving local water systems, the project will provide critical training for Wayne State students to become experts in wastewater treatment and environmental protection. 

    “This collaboration with Wayne State University represents the kind of innovation-focused partnerships that strengthen our ability to protect the region’s water resources,” said Dr. John Norton, director of energy, research and innovation at GLWA. “Through this research, we will not only enhance our treatment capabilities at the WRRF but also help train the next generation of water professionals.”

    “This collaboration is an excellent example of Wayne State’s Grand Challenges initiative, which aims to address increasingly complex problems and how we can deliver real-world solutions that impact our local communities and beyond,” said Dr. Ezemenari M. Obasi, vice president for research & innovation at Wayne State. “This project will aid in driving lifelong health and fostering sustainable environments — two of the major themes of our initiative — by creating discoveries that will improve lives and our critical environmental resources.”

    The project team includes McElmurry; Dr. Timothy Dittrich (co-PI), associate professor of civil and environmental engineering, Wayne State; Brooke Ballard, MSESE student, GLWA; Norton; and Dr. Andrew Marcus, senior research engineer, GLWA.

  • Nanexa Demonstrates Feasibility of Quarterly Semaglutide Dosing with PharmaShell®

    Uppsala, Sweden. March 20. Nanexa AB on March 19 announced highly promising new results from its long‑acting semaglutide program, developed using the company’s proprietary PharmaShell® drug delivery platform. Building on the breakthrough monthly‑dosing PK data reported in January 2026, Nanexa has now completed a pharmacokinetic study in rats using several PharmaShell® semaglutide formulations. These new data, in combination with human modelling, indicate that semaglutide can potentially be administered once every three months (quarterly) while maintaining a controlled and therapeutically relevant plasma concentration.

    PharmaShell® encases active pharmaceutical ingredients at the atomic level in a highly protective, extremely thin film coating (approximately 30 nm thick) of slow-dissolving non-toxic inorganic oxides. The platform provides exceptional control of release rate, enabling long, smooth PK profiles with very low ratio between the maximum and minimum plasma concentration.

    New Rat Data Supports Ultra‑Long Release with Exceptionally Smooth Plasma Concentration Profile

    Using this dataset, Nanexa applied established pharmacokinetic models to simulate repeated dosing in humans. These simulations demonstrate that PharmaShell®‑coated semaglutide can achieve and maintain therapeutic plasma levels using once‑quarterly subcutaneous injections, with ratio between the maximum and minimum plasma concentration significantly lower than typically observed for weekly administration of the marketed product Wegovy® (semaglutide).

    Lower initial plasma concentration peaks are considered key to minimizing gastrointestinal side effects such as nausea — a major reason for treatment discontinuation in GLP‑1 therapies. By enabling a smoother and more tolerable exposure profile, PharmaShell® could markedly improve adherence and overall patient experience.

    A Major Step Forward for Long‑Acting GLP‑1 Therapies

    “These new results represent another important milestone for Nanexa,” said David Westberg, CEO of Nanexa. “Demonstrating the potential for quarterly dosing of semaglutide is exceptional, and — as far as we know — no one else has shown this before. This further underscore the unique capability of PharmaShell® to control release rates for complex peptides and reinforces our position as a leader in long‑acting GLP‑1 development. We see significant commercial and therapeutic potential in these findings.”

    The new data build on the clinical Phase 1 results from Nanexa’s liraglutide program, reported in 2025, which provided essential human validation of the PharmaShell® technology. These learnings have accelerated development, improved modelling accuracy, and strengthened the path toward clinical readiness.

  • JobElephant Recognized for Innovation in Job Advertising and Excellence in Client Success

    SAN DIEGO, Calif. March 20, 2026 – JobElephant, a leading recruitment advertising technology company, has been named a finalist in two categories of The Digital Job Advertising Excellence Awards (DJAx Awards). The company earned recognition in the Excellence in Client Success and Support – Niche Job Advertiser category and the Innovation in Job Advertising – Supplier category, with winners to be announced on May 14 at the awards ceremony in London.

    “Being named a finalist demonstrates how we’ve successfully balanced innovation with service excellence,” said Michael Ang, CEO of JobElephant. “These nominations reflect our commitment to delivering solutions that not only advance the industry but also drive measurable results for our clients.”

    The DJAx Awards maintain rigorous judging standards that make finalist status a significant industry achievement. Each entry undergoes independent evaluation by at least three expert judges drawn from seasoned job board leaders, digital recruitment innovators, and senior industry practitioners who score submissions using consistent criteria and weighted scoring matrices. Judges work independently to prevent bias and cannot assess categories where they have existing business relationships with entrants. Only entries meeting minimum benchmark scores advance to the shortlist.

    The Innovation recognition highlights JobElephant’s solutions that address the fragmentation of recruitment technology where job boards operate independently from applicant tracking systems, creating inefficiencies that cost organizations time, money, and top candidates. JobElephant introduced Surus for Applicant Tracking System (ATS) integration and JobStats, a real-time Business Intelligence (BI) dashboard that tracks performance from view to hire. JobStats connects Apptrkr and Surus data in Microsoft Power BI, giving customizable, shareable dashboards across recruiting teams. This technology provides transparency and end-to-end visibility into the hiring funnel, enabling clients to make informed advertising decisions.

    The Excellence in Client Success nomination celebrates JobElephant’s customer success team. The team builds tailored media plans that leverage Horton®, JobElephant’s proprietary predictive analytics tool, to guide ad spend toward the highest-performing job boards and publications. This approach enables organizations to optimize their recruitment advertising investments while attracting diverse, qualified candidates across higher education, government, nonprofit, and healthcare sectors.

    JobElephant continues to address recruitment technology fragmentation through innovative solutions and remains dedicated to helping clients achieve maximum ROI through its proprietary Horton® predictive analytics tool and personalized customer success approach.  

  • AppViewX Acquires Eos, Expands Leadership in AI and Machine Identity Security

    New York, NY – March 19, 2026 – AppViewX, a leading machine identity management provider, today announced it has acquired Eos, an AI-native Identity Control Plane for AI agents and autonomous workloads within the enterprise. By combining AppViewX’s automated CLM and PKI with Eos’s agentic governance and privileged access control, the platform delivers an integrated solution for AI agent and machine identity security. The acquisition accelerates AppViewX’s evolution into an AI-native platform, positioning the company as a leader in securing machines, workloads, and AI agents in cloud and hybrid environments.

    Additionally, Archit Lohokare, Co-founder and Chief Executive Officer of Eos, has been appointed Chief Executive Officer of AppViewX, succeeding Dino DiMarino, who has stepped down as the company’s Chief Executive Officer to pursue other opportunities. 

    Mr. Lohokare brings more than two decades of experience in cybersecurity across Identity Security, Data Security, and Endpoint Security. Prior to founding Eos, Mr. Lohokare was the Senior Vice President and General Manager of the Workforce and Endpoint Security business at CyberArk, where he was instrumental in creating CyberArk’s next-generation Identity Security Platform. His deep expertise in identity security will guide AppViewX through its next phase of platform expansion in the AI and quantum era.

    “AI agents are increasingly acting with autonomy inside the enterprise, with privileged access to data, applications, infrastructure, and cloud environments,” said Archit Lohokare, Chief Executive Officer of AppViewX. “Identity is the control plane for this new era. As organizations rapidly deploy AI agents, they need a unified governance and risk layer that secures machines and AI agents with consistent visibility, policy, and enforcement. By combining AppViewX’s leadership in machine identity with Eos’s AI-native capabilities, we are building the next-generation platform enterprises need to innovate confidently and securely at AI scale.”

    Additionally, Kashyap Ivaturi, Co-founder and Chief Technology Officer of Eos, will be joining AppViewX as Chief Technology Officer and Madhu Venkatarajan, current AppViewX Chief Technology Officer, will be assuming the role of Chief Engineering Officer and General Manager of India Operations, focusing on scaling engineering excellence, accelerating product delivery, and strengthening AppViewX’s India-based innovation and execution capabilities. Mr. Ivaturi has led large-scale global enterprise engineering organizations at CyberArk and ServiceNow and brings extensive experience building secure, scalable SaaS platforms for global enterprises. His leadership will accelerate AppViewX’s product innovation and AI-native roadmap.

    “As organizations scale AI agents and autonomous workloads, the identity-driven attack surface expands dramatically,” said Ian Loring, Senior Managing Director & Executive Chair at Haveli Investments. “AppViewX has established leadership in machine identity management, and the addition of Eos accelerates its evolution into a unified platform that governs machines, AI workloads, and autonomous agents. We are confident that this combination, in addition to Archit’s and Kashyap’s leadership of the new company, will position AppViewX for long-term category leadership and durable growth.” 

    “AI agents are a new identity group, and their rapid proliferation creates new risks for the enterprise,” said John Barrow, Chief Information Security Officer at JB Poindexter. “These agents often behave non-deterministically. To reduce risk, we must monitor, audit, and control their privileged access to sensitive data and systems and ensure their lifecycle is automated and governed. I’m excited to see AppViewX and Eos come together. Eos’s AI agent Identity Security platform combined with AppViewX’s Machine Identity Security platform positions AppViewX as the leader in Machine and AI Agent Identity Security.”

    The acquisition of Eos adds to AppViewX’s growing market momentum and leadership recognition from both the IDC MarketScape for Certificate Lifecycle Management (CLM) and KuppingerCole’s Non-Human Identity Management (NHIM) Leadership Compass

  • National Launch: Strategist Responds to Leadership Development Gap With New Framework

    CARMEL, Ind., March 19, 2026 — Scott Abbott, four-time founder and CEO, investor, coach and bestselling author, today announced the national launch of The Leadership Development Experience with Scott Abbott, a high-impact leadership solution designed to help organizations build, run and scale great companies through stronger leaders.

    “As business accelerates under the pressure of AI, shifting workforce expectations and economic volatility, many organizations are investing in tools — but underinvesting in leadership skills,” Abbott said, adding that his new offering addresses that gap directly.

    The Leadership Development Experience is an integrated program that combines:

    • A high-impact keynote: Moments to Momentum • Executive coaching and real-time strategic application • Ongoing leadership learning and development with the BOS-UP Moments book

    “This is not just a speech or one-off training,” said Abbott. “It’s a structured leadership experience to create clarity, alignment and disciplined execution inside organizations.”

    The program is built for performance-driven CEOs, executive teams, HR leaders and conference organizers seeking more than inspiration. It is designed to produce operational clarity, healthier accountability and measurable performance improvement.

     

    Why Now

    • Leadership capability is becoming a competitive advantage. • High performers expect growth, development and meaningful contribution. • Tools cannot replace judgment, clarity and disciplined execution. • Conferences and events are demanding actionable value — not generic inspiration.

    The Leadership Development Experience with Scott Abbott is now available for conferences, corporate events and private organizational engagements nationwide.

    For more information or booking inquiries, visit: www.leadwithscott.com.

  • Cathy Tie Launches Origin Genomics to Advance Responsible Germline Gene Correction in the United States

    New U.S.-Based Company Founded by Serial Biotech Entrepreneur, Cathy Tie, Will Focus on Responsible Germline Gene Correction Under IRB Oversight
     
    New York, NY – March 19, 2026 – Serial Biotech Entrepreneur, Cathy Tie, today announced the launch of Origin Genomics, a New York–based company dedicated to advancing precision germline gene correction for severe inherited diseases. The company launch follows the constructive conclusion of Manhattan Genomics. Cathy Tie is now launching the next chapter of her work, continuing to advance responsible genomic medicine.
     
    Origin Genomics will operate exclusively in the United States, with research conducted under independent IRB oversight and in compliance with applicable federal and state regulations. The company is focused on research of diseases caused by well-characterized nuclear DNA mutations that may be addressable through high-precision genome correction. In addition, Origin Genomics intends to offer Mitochondrial Replacement Therapy (MRT) in the United States for patients affected by mitochondrial DNA–related diseases, contingent upon the passage of proposed federal or state legislation that would authorize the procedure. MRT is already permitted in countries such as the United Kingdom and Australia, and emerging state-level regulatory initiatives in the U.S. suggest a potential pathway for carefully controlled clinical use in cases involving debilitating or life-threatening conditions.
     
    “Genome editing science has advanced significantly over the past decade,” said Tie. “Our responsibility now is to develop this technology carefully, transparently, and within clear regulatory frameworks. Origin Genomics is focused on building the scientific and ethical foundation required for responsible progress. We’ve also already assembled an exceptional team of specialists across gene editing and embryology, alongside leading professors and a key policy advisor who helped lead the state-level regulatory change that made experimental therapies possible. That combination of scientific expertise and regulatory insight is essential to ensuring this work moves forward responsibly.”
     
    The company’s research roadmap centers on improving editing fidelity, reducing mosaicism, and conducting rigorous off-target analysis in early embryonic contexts. Origin Genomics will prioritize serious, well-characterized heritable diseases and will advance only when safety thresholds are met. The company is solely focused on research.
  • NCATM 2026 Concludes at CIMP Patna, Highlights Role of Technology in Transforming Agriculture

    Patna, March 19, 2026: The National Conference on Agriculture Technology and Management (NCATM 2026) was successfully held today at Chandragupt Institute of Management Patna (CIMP) in a hybrid format, bringing together academicians, policymakers, researchers, and industry experts to explore the transformative role of technology and management in agriculture.

    NCATM 2026 Concludes at CIMP Patna, Highlights Role of Technology in Transforming Agriculture

    The conference commenced with an inaugural session at the CIMP Auditorium, graced by eminent academicians including Prof. (Dr.) Rana Singh, Director of CIMP, Prof. (Dr.) Ankit Sharma and other distinguished faculty members. In his welcome address, Prof. (Dr.) Rana Singh emphasized the need for collaborative platforms to address emerging agricultural challenges. A conference overview was presented by Prof. (Dr.) Vijaya, who underlined its interdisciplinary relevance in the current agricultural landscape.

    NCATM 2026 Concludes at CIMP Patna, Highlights Role of Technology in Transforming Agriculture

    The Chief Guest, Dr. Birendra Prasad Yadav, I.A.S., Special Secretary, Agriculture Department, Government of Bihar, delivered a keynote address highlighting the transformative impact of technology across sectors such as agriculture, healthcare, and the broader economy. He stressed that technological advancements are critical to enhancing productivity, ensuring food security, and achieving sustainable development. He also emphasized the importance of green technologies and effective management practices in driving agricultural growth. The inaugural session concluded with a vote of thanks by Ranjani Ram.

    NCATM 2026 featured five technical sessions covering a wide range of themes. Key discussions focused on agri-business challenges, green recruitment practices, and the role of foreign direct investment (FDI) in Bihar’s agricultural transformation. Experts also deliberated on emerging areas such as artificial intelligence, digitalization, Farmer Producer Organisations (FPOs), agri-fintech, and circular economy practices.

    The sessions showcased innovations in smart farming and precision agriculture, alongside new agri-based industrial models promoting rural entrepreneurship and sustainability. Mechanization advancements, including efficient harvesting systems, and strategic management approaches for agri-business SMEs were also highlighted. Notably, research presentations on deep learning applications—such as automated soybean seed grading—demonstrated the growing potential of advanced technologies in improving agricultural productivity and accuracy.

    The valedictory session marked the conclusion of the conference, with Dr. Nitish Nigam presenting a comprehensive summary of the technical deliberations. He highlighted key themes including IoT, AI-driven analytics, agri-fintech, and evolving policy frameworks. The session also recognized academic excellence through the presentation of Best Paper Awards to outstanding contributors.

    Dr. Nitish Nigam delivered the vote of thanks, expressing gratitude to the Director, faculty members including Prof. (Dr.) Ankit Sharma and Prof. (Dr.) Vijaya, the organizing team, participants, and volunteers for their contributions in making the conference a success.

    Overall, NCATM 2026 emerged as a significant academic platform, reinforcing the importance of innovation, collaboration, and sustainable practices in shaping the future of agriculture.

  • Gujarat Detects Over 3,000 Pre Cancer Oral Cancer Cases in 2025 Screening Drive

    Gujarat has identified more than 3,000 pre-cancerous oral cancer cases in 2025 through an expanded statewide screening programme, according to health officials.

    The initiative, carried out across government hospitals, health centres, and mobile camps, focuses on early detection among high-risk groups, particularly tobacco users. Most of the cases detected were in the early stages, allowing for timely treatment and counselling.

    Health authorities said the drive highlights the importance of preventive healthcare and increased awareness of oral cancer symptoms such as persistent mouth sores, unusual patches, and difficulty in chewing.

    Officials added that outreach efforts in rural and semi-urban areas have helped improve early diagnosis and reduce the risk of late-stage complications.

  • Gold Declined Amid Changing Monetary Policy Expectations

    Today’s markets analysis on behalf of Konstantinos Chrysikos Head of Customer Relationship Management at Kudotrade

    Gold extended its losing streak on Thursday, falling to its weakest point in multiple weeks as interest rate expectations continued to shift toward fewer rate cuts. The Federal Reserve kept its interest rates unchanged as inflationary concerns continue to be fueled by rising oil prices. With forecasts now pricing out near-term easing entirely, pushing the first expected cut until next year, yields have firmed, eroding gold’s appeal as a non-yielding asset.

    Looking ahead, gold’s near-term trajectory could remain weighed down by the current inflationary concerns. In this regard, the market could remain exposed to the developments in the Middle East and their impact on energy prices. The current limited visibility for an off-ramp for the tensions in the region could continue to put pressure on gold. New economic data could also affect the metal to a certain extent if monetary policy views change drastically. Today’s jobless claims data could shed some light on the state of the job market, although its impact could be limited under current conditions.